Region:   International United States Sweden

Jul 7, 2023  ·  Regulatory information

Michael Forss new CFO for Bioservo Technologies

Bioservo Technologies AB (publ) (Nasdaq First North: BIOS) today announces that the company has contracted Michael Forss as new interim CFO and member of the management team. Michael succeeds Madeleine Börjesson as CFO and will take up the position on July 7, 2023.

Michael has a background as an auditor and partner at EY with long and valuable experience of public companies in an international environment. Since 2019, Michael works in his own consulting company with advice in financial accounting, reporting and business management.

Bioservo would like to take the opportunity to thank resigning CFO Madeleine Börjesson for her valuable contribution to the company and wish her all the best in the future.

For more information, please contact,
Petter Bäckgren, CEO, Bioservo Technologies AB
Phone: +468 21 17 10

Mikael Wester, Marketing Director, Bioservo Technologies AB
Phone: +468 21 17 10

About Bioservo Technologies
Bioservo Technologies AB (publ) is a world-leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy, and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health of workers and to improve the quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.

FNCA Sweden AB is the company’s Certified Adviser on Nasdaq First North.
For more information, please visit